234 related articles for article (PubMed ID: 25894041)
21. [How far the rates of cholesterol have to be lowered in primary prevention?].
Rodondi N
Rev Med Suisse; 2010 Mar; 6(239):483-4. PubMed ID: 20373693
[No Abstract] [Full Text] [Related]
22. Statins for primary prevention of cardiovascular disease.
Majeed A
BMJ; 2014 May; 348():g3491. PubMed ID: 24868092
[No Abstract] [Full Text] [Related]
23. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
Kazi DS; Penko JM; Bibbins-Domingo K
Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score in patients with elevated C-reactive protein.
MacDonald GP
J Am Osteopath Assoc; 2010 Aug; 110(8):427-36. PubMed ID: 20805548
[TBL] [Abstract][Full Text] [Related]
25. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and cost-effectiveness of statins in low-risk patients.
Gupta AK
CMAJ; 2011 Nov; 183(16):1821-3. PubMed ID: 22025650
[No Abstract] [Full Text] [Related]
27. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
Corrao G; Scotti L; Zambon A; Baio G; Nicotra F; Conti V; Capri S; Tragni E; Merlino L; Catapano AL; Mancia G
Atherosclerosis; 2011 Aug; 217(2):479-85. PubMed ID: 21592477
[TBL] [Abstract][Full Text] [Related]
28. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
Marshall T
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of statin therapy for the primary prevention of coronary heart disease.
Walshe V; Nash A; Barry M
Ir Med J; 2006 May; 99(5):144-5. PubMed ID: 16892920
[TBL] [Abstract][Full Text] [Related]
30. A Reappraisal of the Safety and Cost-Effectiveness of Statin Therapy in Primary Prevention.
Bleakley C; Pumb R; Harbinson M; McVeigh GE
Can J Cardiol; 2015 Dec; 31(12):1411-4. PubMed ID: 26386731
[TBL] [Abstract][Full Text] [Related]
31. Cost and effectiveness of cardiovascular prevention.
Boyar A
Am J Cardiol; 2007 Nov; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815
[No Abstract] [Full Text] [Related]
32. "Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.
Messori A; Santarlasci B; Trippoli S; Vaiani M
BMJ; 2003 Oct; 327(7418):808-9; discussion 809; author reply 809-10. PubMed ID: 14525889
[No Abstract] [Full Text] [Related]
33. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.
Gotto AM
Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952
[No Abstract] [Full Text] [Related]
34. Statins in women for primary prevention--is there evidence to back up their use??
Fenton A; Panay N
Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236
[No Abstract] [Full Text] [Related]
35. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
36. Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma.
Aronow WS
J Am Geriatr Soc; 2009 Oct; 57(10):1942-3; author reply 1943-4. PubMed ID: 19807799
[No Abstract] [Full Text] [Related]
37. Management of hyperlipidemia in older adults.
Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
[TBL] [Abstract][Full Text] [Related]
38. [Primary prevention of cardiovascular diseases with statins in patients with diabetes].
Macías Saint-Gerons D; de la Fuente Honrubia C; de Andrés-Trelles F; Catalá-López F
Med Clin (Barc); 2015 Mar; 144(6):285-7. PubMed ID: 24954712
[No Abstract] [Full Text] [Related]
39. Summaries for patients. The cost-effectiveness of aspirin, statins, or both drugs in the primary prevention of heart disease.
Ann Intern Med; 2006 Mar; 144(5):I29. PubMed ID: 16520469
[No Abstract] [Full Text] [Related]
40. Statins for primary prevention of cardiovascular disease.
Deckers JW; Blumenthal RS
BMJ; 2011 Feb; 342():d1048. PubMed ID: 21325384
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
